Amiodarone-induced thyroid dysfunction in Taiwan: a retrospective cohort study

被引:14
作者
Huang, Chun-Jui [1 ,2 ]
Chen, Po-Ju [1 ]
Chang, Jing-Wen [3 ]
Huang, De-Feng [2 ,4 ]
Chang, Shih-Lin [2 ,5 ]
Chen, Shih-Ann [2 ,5 ]
Jap, Tjin-Shing [1 ,2 ]
Lin, Liang-Yu [1 ,2 ,6 ]
机构
[1] Taipei Vet Gen Hosp, Dept Med, Div Endocrinol & Metab, Taipei, Taiwan
[2] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan
[3] Kaohsiung Armed Forces Gen Hosp, Dept Med, Kaohsiung, Taiwan
[4] Taipei Vet Gen Hosp, Dept Med, Div Allergy Immunol & Rheumatol, Taipei, Taiwan
[5] Taipei Vet Gen Hosp, Dept Med, Div Cardiol, Taipei, Taiwan
[6] Natl Yang Ming Univ, Inst Pharmacol, Taipei 112, Taiwan
关键词
Amiodarone; Hypothyroidism; Thyrotoxicosis; CONGENITAL HEART-DISEASE; INDUCED THYROTOXICOSIS; INDUCED HYPOTHYROIDISM; FOLLOW-UP; RISK-FACTORS; MANAGEMENT; PREDICTABILITY; COMMUNITY; DIAGNOSIS; THERAPY;
D O I
10.1007/s11096-013-9910-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background The incidence and risk factors of amiodarone-induced thyroid dysfunction are variable in the literature. Objective The aim of this study was to investigate the clinical and biochemical features and risk factors of amiodarone-induced thyroid dysfunction in Taiwan. Setting This study was conducted at a tertiary referral center for arrhythmia. Method Retrospective analysis of patients treated with amiodarone during the years 2008-2009 was performed. Main outcome measure Incidence and risk factors of amiodarone-induced thyrotoxicosis (AIT) and amiodarone-induced hypothyroidism (AIH) were assessed. Results Of the 527 patients, 437 (82.9 %) remained euthyroid, 21 (4.0 %) developed AIT, and 69 (13.1 %) were affected with AIH. In univariate analysis, AIT was associated with younger age, and the risk factors for AIH included older age, higher baseline thyroid stimulating hormone (TSH) titer, lower baseline free T4 level, lower cumulative amiodarone dosage, and shorter amiodarone treatment duration. Cox regression analysis was performed to determine the different risk categories in the elderly population of age 65-74 (young-old), 75-84 (old-old), and a parts per thousand yen85 years old (oldest-old). Additionally increased risk of AIH was found in the groups of old-old (HR 2.09, 95 % CI 1.11-3.96) and oldest-old (HR 2.57, 95 % CI 1.21-4.75). In the multivariate analysis of risk factors for AIH, baseline TSH level (HR 1.38, 95 % CI 1.12-1.70) and cumulative amiodarone dosage (HR 0.95, 95 % CI 0.93-0.97) remained statistically significant. Conclusion AIH was much more common than AIT in Taiwan, an area with sufficient iodine intake. Higher baseline TSH level was the predominant independent risk factor for the development of AIH.
引用
收藏
页码:405 / 411
页数:7
相关论文
共 32 条
  • [1] Determinants and outcome of amiodarone-associated thyroid dysfunction
    Ahmed, Sheba
    Van Gelder, Isabelle C.
    Wiesfeld, Ans C. P.
    Van Veldhuisen, Dirk J.
    Links, Thera P.
    [J]. CLINICAL ENDOCRINOLOGY, 2011, 75 (03) : 388 - 394
  • [2] Aleksic Zeljka, 2011, Med Pregl, V64, P533
  • [3] Serum TSH within the Reference Range as a Predictor of Future Hypothyroidism and Hyperthyroidism: 11-Year Follow-Up of the HUNT Study in Norway
    Asvold, Bjorn O.
    Vatten, Lars J.
    Midthjell, Kristian
    Bjoro, Trine
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (01) : 93 - 99
  • [4] Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association
    Bartalena, L
    Wiersinga, WM
    Tanda, ML
    Bogazzi, F
    Piantanida, E
    Lai, A
    Martino, E
    [J]. CLINICAL ENDOCRINOLOGY, 2004, 61 (04) : 494 - 502
  • [5] Thyroid function abnormalities during amiodarone therapy for persistent atrial fibrillation
    Batcher, Elizabeth L.
    Tang, X. Charlene
    Singh, Bramah N.
    Singh, Steven N.
    Reda, Domenic J.
    Hershman, Jerome M.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2007, 120 (10) : 880 - 885
  • [6] The various effects of amiodarone on thyroid function
    Bogazzi, F
    Bartalena, L
    Gasperi, M
    Braverman, LE
    Martino, E
    [J]. THYROID, 2001, 11 (05) : 511 - 519
  • [7] Bongard Vanina, 2006, Am J Ther, V13, P315, DOI 10.1097/00045391-200607000-00007
  • [8] Amiodarone-induced thyroid dysfunction associated with cumulative dose
    Bouvy, ML
    Heerdink, ER
    Hoes, AW
    Leufkens, HGM
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2002, 11 (07) : 601 - 606
  • [9] Monitoring the use of amiodarone: compliance with guidelines
    Burgess, C
    Blaikie, A
    Ingham, T
    Robinson, G
    Narasimhan, S
    [J]. INTERNAL MEDICINE JOURNAL, 2006, 36 (05) : 289 - 293
  • [10] Effects of amiodarone therapy on thyroid function
    Cohen-Lehman, Janna
    Dahl, Peter
    Danzi, Sara
    Klein, Irwin
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2010, 6 (01) : 34 - 41